Insights on ErbB glycosylation–contributions to precision oncology
… glycosylation has been demonstrated to influence ErbB-dependent oncogenicity. Indeed,
in glycoengineered gastrointestinal cancer cell models devoid of selected O-glycosylation …
in glycoengineered gastrointestinal cancer cell models devoid of selected O-glycosylation …
Advances in the Discovery of Novel Biomarkers for Cancer: Spotlight on Protein N-Glycosylation
W Zhang, Z Yang, X Gao, Q Wu - Biomarkers in Medicine, 2020 - Taylor & Francis
… focused on N-glycosylation and cancer biomarkers. We … role of glycosylation in tumorigenesis
and progression. Then we introduced some typical glycosylation-related markers in cancer …
and progression. Then we introduced some typical glycosylation-related markers in cancer …
Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer
G Greville, A McCann, PM Rudd, R Saldova - Epigenetics, 2016 - Taylor & Francis
… many cancers. There is sparse knowledge on the impact of these therapies on glycosylation.
… and epigenetic regulation has on cancer cell glycosylation in relation to resultant tumor cell …
… and epigenetic regulation has on cancer cell glycosylation in relation to resultant tumor cell …
[HTML][HTML] Abnormal glycosylation of cancer stem cells and targeting strategies
T Khan, H Cabral - Frontiers in oncology, 2021 - frontiersin.org
… , or N-glycosylation … glycosylation of cellular pathways and markers involved in CSCs
maintenance and resistance mechanisms. The possibilities to use the glycosylation of both cancer …
maintenance and resistance mechanisms. The possibilities to use the glycosylation of both cancer …
[HTML][HTML] Epigenetic bases of aberrant glycosylation in cancer
F Dall'Olio, M Trinchera - International journal of molecular sciences, 2017 - mdpi.com
… in cancer. We see how different epigenetic mechanisms converge to regulate specific pathways
of cancer-… We also summarize the case of O-linked GlcNAc, in which glycosylation is not …
of cancer-… We also summarize the case of O-linked GlcNAc, in which glycosylation is not …
[HTML][HTML] … into bioinformatic applications for glycosylation: instigating an awakening towards applying glycoinformatic resources for cancer diagnosis and therapy
M Muthu, S Chun, J Gopal, V Anthonydhason… - International Journal of …, 2020 - mdpi.com
… This is the first review to look at the use of glycosylation bioinformatics data in cancer … of
glycosylation in cancer. The achievements made using bioinformatics in the area of glycosylation …
glycosylation in cancer. The achievements made using bioinformatics in the area of glycosylation …
[HTML][HTML] Glycosylation in cancer: interplay between multidrug resistance and epithelial-to-mesenchymal transition?
LM Fonseca, VA Silva, L Freire-de-Lima… - Frontiers in …, 2016 - frontiersin.org
… dedicated to discovering glycosylation patterns common to different resistant cancer cell
lines, it will be interesting to see the effect that these discoveries will have on cancer diagnosis, …
lines, it will be interesting to see the effect that these discoveries will have on cancer diagnosis, …
Glycosylation in bladder cancer
C Ohyama - International journal of clinical oncology, 2008 - Springer
… and histology of non-small cell lung cancers.These findings may indicate the equivocal … ,
the clinical implication of GnT-V expression differs among different types of cancer. Takahashi et …
the clinical implication of GnT-V expression differs among different types of cancer. Takahashi et …
Glycosylation of liver acute‐phase proteins in pancreatic cancer and chronic pancreatitis
A Sarrats, R Saldova, E Pla, E Fort… - … –Clinical …, 2010 - Wiley Online Library
… increase in the α-1→3 fucosylation of FET (2.5-fold) in the pancreatitis patients that should
be further investigated with more serum samples to define a possible clinical implications. …
be further investigated with more serum samples to define a possible clinical implications. …
Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine
V Padler-Karavani - Cancer letters, 2014 - Elsevier
… in cancer personalized-medicine aims at glycosylation. Cells … In cancer, the characteristic
cell surface glycosylation is … response that can exacerbate cancer. This review highlights …
cell surface glycosylation is … response that can exacerbate cancer. This review highlights …